Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Electroconvulsive Therapy | 1 | 2016 | 16 | 0.470 |
Why?
|
| Parkinson Disease, Secondary | 1 | 2015 | 8 | 0.470 |
Why?
|
| Mental Disorders | 2 | 2016 | 1163 | 0.460 |
Why?
|
| Haloperidol | 1 | 2015 | 32 | 0.460 |
Why?
|
| Amphetamine-Related Disorders | 1 | 2015 | 52 | 0.440 |
Why?
|
| Methamphetamine | 1 | 2015 | 74 | 0.430 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2015 | 127 | 0.400 |
Why?
|
| Psychotic Disorders | 1 | 2015 | 189 | 0.380 |
Why?
|
| Needs Assessment | 1 | 2013 | 402 | 0.320 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2013 | 778 | 0.290 |
Why?
|
| Opioid-Related Disorders | 1 | 2017 | 602 | 0.280 |
Why?
|
| Patient-Centered Care | 1 | 2013 | 547 | 0.280 |
Why?
|
| Mental Health Services | 1 | 2013 | 473 | 0.270 |
Why?
|
| Analgesics, Opioid | 1 | 2017 | 1149 | 0.270 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2017 | 1371 | 0.260 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2016 | 1419 | 0.250 |
Why?
|
| Health Services Accessibility | 1 | 2013 | 1101 | 0.220 |
Why?
|
| Veterans | 2 | 2019 | 1635 | 0.180 |
Why?
|
| Korsakoff Syndrome | 1 | 2019 | 2 | 0.150 |
Why?
|
| Diphenhydramine | 1 | 2015 | 36 | 0.110 |
Why?
|
| Substance Abuse Treatment Centers | 1 | 2015 | 49 | 0.110 |
Why?
|
| Substantia Nigra | 1 | 2015 | 63 | 0.110 |
Why?
|
| Injections, Intramuscular | 1 | 2015 | 146 | 0.110 |
Why?
|
| Treatment Refusal | 1 | 2015 | 98 | 0.110 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2015 | 93 | 0.110 |
Why?
|
| Dietary Supplements | 1 | 2019 | 583 | 0.110 |
Why?
|
| Nucleus Accumbens | 1 | 2015 | 134 | 0.100 |
Why?
|
| Drug Interactions | 1 | 2015 | 405 | 0.100 |
Why?
|
| Neural Pathways | 1 | 2015 | 313 | 0.100 |
Why?
|
| Patient Admission | 1 | 2015 | 220 | 0.100 |
Why?
|
| Physicians, Primary Care | 1 | 2016 | 208 | 0.100 |
Why?
|
| Warfare | 1 | 2013 | 99 | 0.090 |
Why?
|
| Alcoholism | 1 | 2019 | 822 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 2028 | 0.080 |
Why?
|
| Patient Readmission | 1 | 2015 | 769 | 0.080 |
Why?
|
| Ambulatory Care | 1 | 2013 | 609 | 0.070 |
Why?
|
| Primary Health Care | 1 | 2019 | 1735 | 0.070 |
Why?
|
| Male | 4 | 2019 | 72843 | 0.060 |
Why?
|
| Nevirapine | 1 | 2004 | 18 | 0.050 |
Why?
|
| Humans | 6 | 2019 | 145475 | 0.050 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 2004 | 87 | 0.050 |
Why?
|
| Drug Resistance, Viral | 1 | 2004 | 126 | 0.050 |
Why?
|
| Adult | 2 | 2015 | 40777 | 0.040 |
Why?
|
| Virus Replication | 1 | 2004 | 521 | 0.040 |
Why?
|
| Thiamine Deficiency | 1 | 2019 | 9 | 0.040 |
Why?
|
| Thiamine | 1 | 2019 | 19 | 0.040 |
Why?
|
| Vitamin B Complex | 1 | 2019 | 39 | 0.040 |
Why?
|
| HIV-1 | 1 | 2004 | 908 | 0.030 |
Why?
|
| Folic Acid | 1 | 2019 | 198 | 0.030 |
Why?
|
| Aged | 1 | 2017 | 26153 | 0.030 |
Why?
|
| Young Adult | 1 | 2013 | 14219 | 0.030 |
Why?
|
| Anti-HIV Agents | 1 | 2004 | 912 | 0.030 |
Why?
|
| United States | 1 | 2013 | 16098 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 1508 | 0.030 |
Why?
|
| Child | 1 | 2013 | 22707 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 2930 | 0.020 |
Why?
|
| Female | 1 | 2013 | 78845 | 0.010 |
Why?
|
| HIV Reverse Transcriptase | 1 | 2004 | 31 | 0.010 |
Why?
|
| Middle Aged | 1 | 2019 | 36215 | 0.010 |
Why?
|
| Mutation | 1 | 2004 | 4075 | 0.010 |
Why?
|